Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 16 | 2020 | 935 | 3.890 |
Why?
|
| Cell Movement | 11 | 2020 | 571 | 3.540 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2018 | 93 | 1.930 |
Why?
|
| Transforming Growth Factor beta | 4 | 2016 | 197 | 1.770 |
Why?
|
| Cell Proliferation | 10 | 2019 | 1198 | 1.650 |
Why?
|
| Prostate | 5 | 2018 | 154 | 1.340 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2019 | 26 | 1.220 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2018 | 15 | 1.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2018 | 269 | 0.880 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 2231 | 0.860 |
Why?
|
| Nodal Protein | 2 | 2012 | 3 | 0.820 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2020 | 46 | 0.800 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 807 | 0.790 |
Why?
|
| Signal Transduction | 8 | 2020 | 1908 | 0.750 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 54 | 0.650 |
Why?
|
| Oxytocin | 3 | 2018 | 25 | 0.620 |
Why?
|
| Phosphorylation | 7 | 2020 | 928 | 0.620 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 54 | 0.610 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2016 | 82 | 0.550 |
Why?
|
| Smad3 Protein | 2 | 2012 | 11 | 0.530 |
Why?
|
| Smad2 Protein | 2 | 2012 | 8 | 0.530 |
Why?
|
| Male | 16 | 2020 | 20025 | 0.500 |
Why?
|
| Androgens | 2 | 2020 | 89 | 0.480 |
Why?
|
| RNA, Messenger | 6 | 2018 | 1207 | 0.460 |
Why?
|
| RNA, Small Interfering | 5 | 2020 | 409 | 0.460 |
Why?
|
| Epidermal Growth Factor | 3 | 2020 | 68 | 0.440 |
Why?
|
| Dinoprostone | 1 | 2013 | 63 | 0.440 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2012 | 1 | 0.430 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2012 | 9 | 0.430 |
Why?
|
| Blotting, Western | 5 | 2012 | 859 | 0.420 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 58 | 0.420 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2012 | 28 | 0.420 |
Why?
|
| Carcinoma | 1 | 2013 | 96 | 0.420 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 161 | 0.390 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 251 | 0.380 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 213 | 0.370 |
Why?
|
| Oxytocics | 1 | 2010 | 8 | 0.370 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 239 | 0.370 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 78 | 0.360 |
Why?
|
| Humans | 16 | 2020 | 37093 | 0.360 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 623 | 0.350 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 539 | 0.330 |
Why?
|
| Testosterone | 1 | 2008 | 193 | 0.300 |
Why?
|
| Cholesterol | 1 | 2008 | 205 | 0.290 |
Why?
|
| Cells, Cultured | 3 | 2012 | 1518 | 0.230 |
Why?
|
| Receptors, Oxytocin | 2 | 2012 | 9 | 0.200 |
Why?
|
| Wound Healing | 2 | 2012 | 70 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 1039 | 0.190 |
Why?
|
| Cell Adhesion | 2 | 2012 | 212 | 0.180 |
Why?
|
| Aminoquinolines | 1 | 2020 | 14 | 0.180 |
Why?
|
| Sirolimus | 1 | 2020 | 60 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 173 | 0.170 |
Why?
|
| Pyrimidines | 1 | 2020 | 118 | 0.170 |
Why?
|
| Microarray Analysis | 1 | 2019 | 61 | 0.170 |
Why?
|
| Oncogene Protein v-akt | 1 | 2018 | 20 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 190 | 0.160 |
Why?
|
| Chemokine CXCL12 | 1 | 2018 | 29 | 0.160 |
Why?
|
| Cell Nucleus | 1 | 2020 | 366 | 0.160 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2018 | 6 | 0.160 |
Why?
|
| Cell Cycle | 1 | 2019 | 326 | 0.150 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 578 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 515 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 114 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2020 | 681 | 0.130 |
Why?
|
| Growth Inhibitors | 1 | 2012 | 26 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 112 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 19 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 131 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 189 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2013 | 444 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 502 | 0.100 |
Why?
|
| DNA Primers | 1 | 2012 | 286 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2012 | 151 | 0.100 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 4 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 433 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 448 | 0.090 |
Why?
|
| Vasopressins | 1 | 2010 | 13 | 0.090 |
Why?
|
| Pertussis Toxin | 1 | 2010 | 27 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 41 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2010 | 49 | 0.090 |
Why?
|
| Base Sequence | 1 | 2012 | 997 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2012 | 384 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 550 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2012 | 587 | 0.080 |
Why?
|
| Protein Binding | 1 | 2012 | 972 | 0.080 |
Why?
|
| Autocrine Communication | 1 | 2008 | 12 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2010 | 308 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 168 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2008 | 513 | 0.070 |
Why?
|
| Rats | 1 | 2012 | 3483 | 0.060 |
Why?
|
| Protein Phosphatase 2 | 1 | 2020 | 22 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2020 | 93 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 126 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 187 | 0.040 |
Why?
|
| RNA Interference | 1 | 2020 | 243 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 674 | 0.040 |
Why?
|
| Animals | 1 | 2012 | 15081 | 0.030 |
Why?
|